至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

CIS is a potent checkpoint in NK cell-mediated tumor immunity.

Nat Immunol. 2016; 
Delconte RB,, Kolesnik TB, Dagley LF,, Rautela J,, Shi W,, Putz EM, Stannard K, Zhang JG,, Teh C,, Firth M,, Ushiki T,, Andoniou CE, Degli-Esposti MA, Sharp PP,, Sanvitale CE, Infusini G, Liau NP,, Linossi EM,, Burns CJ,, Carotta S,, Gray DH,, Seillet C,, Hutchinson DS, Belz GT,, Webb AI,, Alexander WS,, Li SS, Bullock AN, Babon JJ,, Smyth MJ,, Nicholson SE,, Huntington ND,.
Products/Services Used Details Operation
Peptide Synthesis Phosphopeptides were obtained from Genscript. Get A Quote

摘要

The detection of aberrant cells by natural killer (NK) cells is controlled by the integration of signals from activating and inhibitory ligands and from cytokines such as IL-15. We identified cytokine-inducible SH2-containing protein (CIS, encoded by Cish) as a critical negative regulator of IL-15 signaling in NK cells. Cish was rapidly induced in response to IL-15, and deletion of Cish rendered NK cells hypersensitive to IL-15, as evidenced by enhanced proliferation, survival, IFN-γ production and cytotoxicity toward tumors. This was associated with increased JAK-STAT signaling in NK cells in which Cish was deleted. Correspondingly, CIS interacted with the tyrosine kinase JAK1, inhibiting its enzymatic activi... More

关键词